Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on June 29, 2026

Jun. 29, 2026

Low grip strength should not be used as an independent predictor of prostate cancer in older men

Indeterminate EIN Presswire

Jun. 29, 2026

The FIFA World Cup puts climate change on the global agenda

Indeterminate EIN Presswire

Jun. 29, 2026

Pfeiffer Honored with ASM PRISM Award for Social Impact Excellence

Indeterminate EIN Presswire

17 hours ago

Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results

Indeterminate GlobeNewswire

17 hours ago

Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition

Indeterminate GlobeNewswire

17 hours ago

FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 22nd YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH

Indeterminate GlobeNewswire

Jun. 29, 2026

Rayca Precision and Data Powered Therapeutics Partner to Advance AI-Designed Nanobody Cancer Therapeutics

Indeterminate EIN Presswire

18 hours ago

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Indeterminate GlobeNewswire

18 hours ago

Beach Day API Launches Real-Time Beach and Ocean Data API for Developers

Indeterminate GlobeNewswire

18 hours ago

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Indeterminate GlobeNewswire

18 hours ago

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Indeterminate GlobeNewswire

18 hours ago

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

Indeterminate GlobeNewswire

Jun. 29, 2026

New Laboratory Tool Opens Door to Better Treatments for Rare and Deadly Melanomas

Indeterminate EIN Presswire

18 hours ago

Digital Realty Announces Secondary Offering of Common Stock by Blackstone

Indeterminate GlobeNewswire

18 hours ago

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Indeterminate GlobeNewswire

18 hours ago

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

Indeterminate GlobeNewswire

18 hours ago

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Indeterminate GlobeNewswire

18 hours ago

Digital Realty Announces Purchase of Blackstone Interest in Three Northern Virginia Data Centers

Indeterminate GlobeNewswire

18 hours ago

QuickBuzz Announces Strong Momentum Following Successful Presentation at the Global Family Investment Summit

Indeterminate GlobeNewswire

18 hours ago

Lakefront Receives Transparency Notification from Madison Avenue Partners

Indeterminate GlobeNewswire